Haverkamp, W., Breithardt, G., Camm, A.J., Janse, M.J., Rosen, M.R., Antzelevitch, C., et al. (2000) The Potential for QT Prolongation and Proarrhythmia by Non-Antiarrhythmic Drugs: Clinical and Regulatory Implications. Report on a Policy Conference of the European Society of Cardiology. European Heart Journal, 21, 1216-1231.
https://doi.org/10.1053/euhj.2000.2249

has been cited by the following article:

• TITLE: Electrocardiographic Manifestations of Endocrine and Metabolic Disorders

  AUTHORS: Masoud Amini, Nasim Golchin, Monica Kharat, Abdullah Mahmood, Issac Sachmechi

  KEYWORDS: Endocrinology, EKG, Cardiovascular, Thyroid, Cushing Syndrome, Electrocardiographic

  JOURNAL NAME: Open Journal of Endocrine and Metabolic Diseases, Vol.13 No.7, July 31, 2023

  ABSTRACT: Endocrine dysfunction has an adverse impact on the cardiovascular system that may be due to an endocrine abnormality that leads to electrocardiogram (EKG) changes. The EKG changes due to endocrine disorder can be reversible and irreversible and treating underlying disease can reverse EKG changes in some cases. In this article, we review the electrocardiogram manifestations of various endocrine disorders.